A retrospective chart review to assess feeding tolerance in adults who had been switched from an intact protein formula to a peptide-based formula due to feeding intolerance in a complex continuing care facility.
Study Type
OBSERVATIONAL
Enrollment
10
Enteral feeding with a peptide-based formula.
Bruyere Research Institute
Ottawa, Ontario, Canada
Feeding tolerance - Gastric residuals
no change, tolerance improved, tolerance worsened
Time frame: Up to 30 days after formula switch
Feeding tolerance - gagging/retching
no change, tolerance improved, tolerance worsened
Time frame: Up to 30 days after formula switch
Feeding tolerance - abdominal distension/gas
no change, tolerance improved, tolerance worsened
Time frame: Up to 30 days after formula switch
Feeding tolerance - vomiting
no change, tolerance improved, tolerance worsened
Time frame: Up to 30 days after formula switch
Feeding tolerance - stool consistency issues
too hard, too loose
Time frame: Up to 30 days after formula switch
Volume of formula consumed in a day vs. goal
documentation of feeding volume after switch as "less than," "about the same as," or "more than" feeding volume achieved before switch
Time frame: Up to 30 days after formula switch
Tube feeding interruptions
Number of tube feeding interruptions
Time frame: Up to 30 days after formula switch
Weight
Measured body weight
Time frame: Prior to and up to 30 days following formula switch.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Medication use
Documented medication use
Time frame: Prior to and up to 30 days following formula switch.
Caloric intake
Measured daily calorie intake
Time frame: Up to 30 days after formula switch
Protein intake
Measured daily protein intake
Time frame: Up to 30 days after formula switch